The European Prevention of Alzheimer’s Dementia (EPAD) project is very pleased to announce the external release of its second wave of data including the baseline data from the first 1.500 research participants (V1500.0).
“This most recent and substantial data release from the EPAD cohort will undoubtedly have a major impact on our understanding of Alzheimer’s disease at very early stages of its development. Releasing this data to the global research community for free and rapid access marks a major milestone for EPAD and will hopefully set a standard for open data access that will ultimately benefit the millions of people worldwide at risk of developing Alzheimer’s dementia.”, said Craig Ritchie, EPAD Co-coordinator.
The previous V500.0 data release went into open access in November 2019. All the data set will be made available via secure online workspaces in order to facilitate collaboration between people and teams with similar research aims. To access the data, you will need to make an online request by visiting the EPAD LCS Research Access Process webpage, where you will find a variety of resources to support your research.
In the chosen nomenclature
- V1500.0: V=version, “1500” is the number of sequentially recruited research participants in each dataset and ‘.0’ refers to the study visit the dataset includes up (visit 0 refers to the baseline data).
- V500.0: V=version, “500” is the number of sequentially recruited research participants in each dataset and ‘.0’ refers to the study visit the dataset includes up (visit 0 refers to the baseline data).
In addition, the EPAD team ais pleased to let you know that the MRI imaging data access for the first 500 participants at baseline (V500.0) is now available to both internal and external researchers. All requests for EPAD LCS MRI data will be recorded by the EPAD LCS Research Access Process. EPAD partners and external researchers will have the possibility to transfer the MRI data and images from the EPAD LCS XNat to their own databases.
If you experience any technical issues or if you want more information please submit your query to email@example.com.